Pharmacy & Therapeutics- July 2008 - (Page 412) CONTINUING EDUCATION CREDIT References 1. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001;17(Suppl 1)S4–S12. 2. Rozen TD, Swanson JW, Stang PE, et al. Increasing incidence of medically recognized migraine headache in a United States population. Neurology 1999;53(7):1468–1473. 3. Stewar t WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA 1992;267(1):64–69. 4. Goldberg LD. The cost of migraine and its treatment. Am J Manag Care 2005;11:S62–S67. 5. Adelman JU, Adelman LC, Freeman MC, et al. Cost considerations of acute migraine treatment. Headache 2004;44:271–285. 6. May A, Goadsby PJ. The trigeminovascular system in humans: Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999;19:115–127. 7. van de Ven RC, Kaja S, Plomp JJ, et al. Genetic models of migraine. Arch Neurol 2007;64:643–646. 8. Hamel E. Serotonin and migraine: Biology and clinical implications. Cephalalgia 2007;27(11):1293–1300. 9. Cady R, Dodick D, Levine H, et al. Sinus headache: A neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc 2005:80(7):908–916. 10. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache 2001;41:638–645. 11. Headache Classification Subcommittee of the International Headache Society. International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24(Suppl.1):1–151. 12. Diener HC, Kaube H, Limmroth V. A practical guide to the management and prevention of migraine. Drugs 1998;56(5):811–824. 13. Lipton RB, Bigal ME, Amatniek JC, et al. Tools for diagnosing migraine and measuring its severity. Headache 2004;44:387–398. 14. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 2003;60:935–940. 15. Tepper SJ. Tailoring management strategies for the patient with menstrual migraine: Focus on prevention and treatment. Headache 2006;46(Suppl 2):S61–S68. 16. Rains JC, Poceta JS, et al. Headache and sleep disorders: Review and clinical implications for headache management. Headache 2006; 46(9):1344–1363. 17. Tietjen GE, Brandes JL, Digre KB, et al. High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 2007;68:134–140. 18. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: Current understanding and treatment. N Engl J Med 2002;346:257–270. 19. Adelman JU, Adelman RD. Current options for the prevention and treatment of migraine. Clin Ther 2001;23(6):772–788. 20. Blau JN. Thavapalan M. Preventing migraine: A study of precipitating factors. Headache 1988;28:481–483. 21. Guarniert P, Radnitz CL, Blanchard EB. Assessment of dietary risk factors in chronic headache. Biofeedback Self-Regulation 1990; 15(1):15–25. 22. Bogucki A. Studies on nitroglycerin and histamine provoked cluster headache attacks. Cephalalgia 1989;22:90–153. 23. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev 2001;6(5):488–494. 24. Bigal ME, Lipton RB. The preventive treatment of migraine. Neurologist 2006;12:204–213. 25. Earles J, Folen RA, James LC. biofeedback using telemedicine: Clinical applications and case illustrations. Behav Med 2001;27: 77–82. 26. Sorbi M, Tellegen B, Du Long A. Long-term effects of training in relaxation and stress. Coping in patients with migraine: A three-year follow-up. Headache 1989;29:111–112. 27. Sheffield MM. Psychosocial interventions in the management of recurrent headache disorders: Policy considerations for implementation. Behav Med 1994;20:74–77. 28. Melchart D, Linde K, Fischer P, et al: Acupuncture for recurrent headaches: A systematic review of randomized controlled trials. Cephalalgia 1999;19:779–786. 29. Streng A, Linde K, Hoppe A. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache 2006;46(10):1492–1502. 30. Pelka RB, Jaenicke C, Gruenwald J. Impulse magnetic-field therapy for migraine and other headaches: A double-blind placebocontrolled study. Adv Ther 2001;18(3):101–109. 31. Norton D. Migraine and photic stimulation: Report on a survey of migraineurs using flickering light therapy. Complement Ther Nurs Midwifery 2000;6:138–142. 32. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the non-pharmacological management of migraine in clinical practice. Canadian Headache Society. Can Med Assoc J 1998;159(1): 47–54. 33. Goslin RE, Gray RN, McCrory DC, et al. Behavioral and physical treatments for migraine headache. Technical review 2. February 1999. Prepared for Agency for Health Care Policy and Research, Contract No. 290-94-2025. Available at: www.clinpol.mc.duke. edu./Pubs/Publications/Behavioral_Manuscript.pdf. Accessed August 2007. 34. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: A meta-analytic review of clinical trials. Pain 1990;42:1–13. 35. Diamond ML, Wenzel RG, Nissan. Optimizing migraine therapy: Evidence-based and patient-centered care. Expert Rev Neurother 2006;6(6):911–919. 36. Silberstein SD, for the U.S. Headache Consor tium. Practice Parameter: Evidence-Based Guidelines for Migraine Headache (An Evidence-Based Review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754–762. 37. Educational Resources and Headache Diaries, National Headache Foundation. Available at: www.headaches.org. Accessed August 2007. 38. Weitzel KW. Thomas ML, Small RE. Migraine: A comprehensive review of new treatment options. Pharmacotherapy 1999;19(8): 957–973. 39. Diamond S, Bigal ME, Silberstein S. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study. Headache 2007;47(3):355–363. 40. Wenzel RG, Lipton RB, Diamond ML, et al. Migraine therapy: A survey of pharmacists’ knowledge, attitudes, and practice patterns. Headache 2005;45:47–52. 41. King DS, Herndon KC. Headache disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. Nor walk, CT: Appleton & Lange; 2005:1105–1121. 42. Alldredge BK. Neurologic disorders: headache. In: Koda-Kimble MA, Young YL, eds. Applied Therapeutics: The Clinical Use of Drugs, 8th ed. Baltimore: Lippincott Williams & Wilkins; 2005:52-1–52-27. 43. Jamieson DG. The safety of triptans in the treatment of patients with migraine. Am J Med 2002;112:135–140. 44. Lipton RB, Stewart WF. Acute migraine therapy: Do doctors understand what migraine patients want from therapy? Headache 1999; 39(Suppl 2):S20–S26. 45. Malik SN, Hopkins M, Young W, Silberstein SD. Acute migraine treatment: Patterns of use and satisfaction in a clincal population. Headache 2006;46:773–780. 46. Remington TL. Headache. In: Berardi RR, McDermott JH, Newton GD, et al., eds. Handbook of Nonprescription Drugs, 14th ed. New York: McGraw-Hill; 2006:69–90. 47. Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: Literature review and recommendations. Pharmacotherapy 2003;23(4):494–505. 48. Lipton RB, Baggish JS, Stewart WF, et al. Efficacy and safety of acetaminophen in the nonprescription treatment of migraine: Results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med 2000;160:3486–3492. 49. Larson BH, Christiansen LV, Andersen B, et al. Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine. Acta Neurol Scand 1990;81(5):464–467. 50. Hamalainen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double- 412 P&T® • July 2008 • Vol. 33 No. 7 http://www.clinpol.mc.duke.edu./Pubs/Publications/Behavioral_Manuscript.pdf http://www.clinpol.mc.duke.edu./Pubs/Publications/Behavioral_Manuscript.pdf http://www.headaches.org
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.